• AG-490: Practical JAK2/EGFR Assay Design

  2026-08-19

  A scenario-driven guide to using AG-490 (JAK2/EGFR inhibitor), SKU A4139, in viability, proliferation, and pathway-validation workflows. It connects reported kinase and cytokine-response data with practical controls for solubility, dose selection, interpretation, and vendor evaluation.

• SIS3: Smad3 Inhibitor for TGF-β Research

  2026-08-19

  SIS3 is a selective Smad3 inhibitor that targets TGF-β/Smad3 signaling without reported inhibition of Smad2 phosphorylation. Peer-reviewed osteoarthritis experiments link SIS3 treatment with lower ADAMTS-5 expression and higher miRNA-140 expression, while product data support broader preclinical fibrosis research applications.

• Sulfo-NHS-SS-Biotin for Surface-Proteome Logic

  2026-08-18

  Sulfo-NHS-SS-Biotin enables water-soluble, reversible labeling of extracellular proteins while preserving a route to distinguish surface residency from molecular association. This guide connects the K1006 workflow to glycoRNA–RNA-binding-protein nanodomains and explains how to design more discriminating cell-surface assays.

• HotStart 2X Green qPCR Master Mix in Pain Translation

  2026-08-18

  A translational framework for using SYBR Green qPCR to connect NTSR1–β-arrestin-2 pain biology with reproducible molecular validation, while recognizing the limits of transcript-level evidence.

• 5-hme-dCTP: A Better Way to Read 5hmC

  2026-08-17

  5-hme-dCTP enables controlled DNA polymerase studies of 5-hydroxymethylcytosine without confusing synthetic nucleotide incorporation with native epigenetic mapping. This guide translates rice drought-response findings into practical assay-selection and reagent-handling decisions.

• GSTA1, Glutathione, and α-Amanitin Hepatotoxicity

  2026-08-17

  A 2026 study identifies GSTA1 as an unexpected driver of α-Amanitin-induced liver injury rather than a purely protective detoxification enzyme. Using mouse toxicology, multi-omics, molecular docking, DARTS, and genetic perturbation in HUH7 cells, the authors connect NRF2-driven GSTA1 upregulation with glutathione depletion, reactive oxygen species accumulation, and hepatocyte damage.

• ABT-263 (Navitoclax) for Apoptosis Research

  2026-08-16

  ABT-263 (Navitoclax) converts Bcl-2-family dependence into a measurable experimental variable for cancer biology, from dose–response apoptosis assays to mitochondrial priming studies. This guide focuses on practical compound handling, model selection, mechanistic readouts, and troubleshooting for reproducible preclinical workflows.

• Ruxolitinib Phosphate: JAK1/2 Research Guide

  2026-08-15

  Ruxolitinib phosphate, also known as INCB018424, is an orally bioavailable selective JAK1/JAK2 inhibitor for research on cytokine signaling, inflammation, and cancer biology. A 2024 anaplastic thyroid carcinoma study linked ruxolitinib exposure to STAT3 suppression, DRP1 transcriptional inhibition, mitochondrial-fission defects, apoptosis, and GSDME-mediated pyroptosis.

• CYR61 and Migrasomes in Irradiated BMSCs

  2026-08-14

  The 2025 study in Stem Cells International identifies CYR61-loaded migrasomes as an extracellular mechanism that improves migration and osteoblastic differentiation in irradiated bone marrow mesenchymal stem cells. Its combination of phenotypic assays, proteomics, molecular interaction studies, and imaging provides a mechanistic framework for investigating cell-based repair of osteoradionecrosis-related bone defects.

• CHK1 Targeting in ER/PR-Stratified Breast Cancer

  2026-08-14

  The reference study shows that CHK1 inhibition does not have a uniform therapeutic effect across breast cancer: it enhances adriamycin sensitivity in ER−/PR−/HER2− models but acts mainly as a single-agent strategy in ER+/PR+/HER2− models. By combining receptor-based stratification, functional assays, and transcriptome analysis, the work links these divergent responses to distinct checkpoint, mitotic, and apoptotic pathways.

• Pronase E (Activity ≥ 7000 U/g) for Reliable Assays

  2026-08-13

  This scenario-driven guide explains how Pronase E (Activity ≥ 7000 U/g), SKU A9953, can support protein digestion, peptide mapping, and proteomic follow-up of cell viability and cytotoxicity experiments without being misused as a direct cell-treatment reagent. It covers compatibility, preparation, interpretation, and practical vendor-selection criteria.

• Tamoxifen Workflows for Cancer and CreER Research

  2026-08-13

  Learn how to deploy Tamoxifen in CreER-mediated gene knockout, breast cancer research, and macrophage–radiation studies. This practical guide connects formulation, assay design, mechanistic controls, and troubleshooting while distinguishing established product data from preclinical workflow suggestions.

• Cinoxacin: Mechanism, Spectrum, and Clinical Evidence

  2026-08-12

  The reference review established Cinoxacin as a bactericidal quinolone antibiotic whose principal value was the combination of bacterial DNA synthesis inhibition, urinary activity against Enterobacteriaceae, and rapid renal delivery. Its findings connect mechanism, susceptibility data, pharmacokinetics, adverse reactions, and clinical outcomes while also identifying important limits, including weak activity against Pseudomonas aeruginosa and Gram-positive cocci.

• H 89 2HCl for cAMP/PKA Signaling Studies

  2026-08-12

  H 89 2HCl provides a practical perturbation tool for separating PKA-dependent phosphorylation from upstream cAMP production in neuronal and pain-signaling assays. This guide translates its biochemical selectivity, cellular use range, and known off-target profile into workflows for neurite outgrowth, calcium-linked neuroinflammation, and mechanotransduction research.

• Naftifine HCl: Assays, Workflows, and Optimization

  2026-08-11

  Naftifine HCl enables controlled investigation of squalene 2,3-epoxidase inhibition, sterol disruption, and fungal membrane phenotypes in research models. This workflow-focused guide covers solvent handling, dose-response design, orthogonal validation, and the careful use of WNT-pathway findings as an experimental design reference rather than a claimed cross-mechanism.

14932 records 1/996 page Next 12345 下5页 Last page